naxagolide has been researched along with prazosin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, JB; Dijkstra, D; Hazelhoff, B; Horn, AS; Mulder, TB; Timmermans, P; Wynberg, H | 1 |
| Boileau, I; Di Ciano, P; Graff-Guerrero, A; Lagzdins, D; Le Foll, B; Lu, SX; Mansouri, E; Mohammed, S; Nakajima, S; Thiruchselvam, T; Wilson, AA | 1 |
2 other study(ies) available for naxagolide and prazosin
| Article | Year |
|---|---|
The hydroxy-hexanydronaphthoxazines: a new group of very potent and selective dopamine agonists.
Topics: 4-Butyrolactone; Animals; Binding, Competitive; Brain Chemistry; Chemical Phenomena; Chemistry; Clonidine; Dopamine; Ergolines; Homovanillic Acid; Humans; In Vitro Techniques; Mianserin; Oxazines; Prazosin; Rats; Receptors, Adrenergic; Receptors, Serotonin; Stereotyped Behavior | 1984 |
Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Brain; Brain Mapping; Dopamine; Female; Humans; Male; Middle Aged; Oxazines; Pilot Projects; Positron-Emission Tomography; Prazosin; Radiopharmaceuticals; Receptors, Adrenergic, alpha-1; Young Adult | 2017 |